Patents by Inventor W. Michael Sheld

W. Michael Sheld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating restenosis with A2A adenosine receptor agonists
    Patent number: 6448235
    Abstract: Agonists of A2A adenosine receptors in combination with rolipram, its derivatives or other Type IV phosphodiesterase (PDE) inhibitors are effective for the treatment of restenosis.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: September 10, 2002
    Assignee: University of Virginia Patent Foundation
    Inventors: Joel M. Linden, Gail W. Sullivan, Ian Sarembock, W. Michael Sheld
  • METHOD FOR TREATING RESTENOSIS WITH A2A ADENOSINE RECEPTOR AGONISTS
    Publication number: 20020082240
    Abstract: Agonists of A2A adenosine receptors in combination with rolipram, its derivatives or other Type IV phosphodiesterase (PDE) inhibitors are effective for the treatment of inflammatory diseases.
    Type: Application
    Filed: April 4, 2000
    Publication date: June 27, 2002
    Inventors: Joel M Linden, Gail W Sullivan, Ian Sarembock, W Michael Sheld